252 related articles for article (PubMed ID: 30429275)
1. Ultrastructural mechanisms of macrophage-induced demyelination in CIDP.
Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
Neurology; 2018 Dec; 91(23):1051-1060. PubMed ID: 30429275
[TBL] [Abstract][Full Text] [Related]
2. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.
Koike H; Kadoya M; Kaida KI; Ikeda S; Kawagashira Y; Iijima M; Kato D; Ogata H; Yamasaki R; Matsukawa N; Kira JI; Katsuno M; Sobue G
J Neurol Neurosurg Psychiatry; 2017 Jun; 88(6):465-473. PubMed ID: 28073817
[TBL] [Abstract][Full Text] [Related]
3. Antibody- and macrophage-mediated segmental demyelination in chronic inflammatory demyelinating polyneuropathy: clinical, electrophysiological, immunological and pathological correlates.
Vallat JM; Mathis S; Vegezzi E; Richard L; Duchesne M; Gallouedec G; Corcia P; Magy L; Uncini A; Devaux J
Eur J Neurol; 2020 Apr; 27(4):692-701. PubMed ID: 31769579
[TBL] [Abstract][Full Text] [Related]
4. Macrophages and Autoantibodies in Demyelinating Diseases.
Koike H; Katsuno M
Cells; 2021 Apr; 10(4):. PubMed ID: 33917929
[TBL] [Abstract][Full Text] [Related]
5. Pathology explains various mechanisms of auto-immune inflammatory peripheral neuropathies.
Vallat JM; Mathis S
Brain Pathol; 2024 Mar; 34(2):e13184. PubMed ID: 37356965
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural mechanisms of macrophage-induced demyelination in Guillain-Barré syndrome.
Koike H; Fukami Y; Nishi R; Kawagashira Y; Iijima M; Katsuno M; Sobue G
J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):650-659. PubMed ID: 32245766
[TBL] [Abstract][Full Text] [Related]
7. Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
Manso C; Querol L; Mekaouche M; Illa I; Devaux JJ
Brain; 2016 Jun; 139(Pt 6):1700-12. PubMed ID: 27017186
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy.
Bosboom WM; van den Berg LH; Franssen H; Giesbergen PC; Flach HZ; van Putten AM; Veldman H; Wokke JH
Brain; 2001 Dec; 124(Pt 12):2427-38. PubMed ID: 11701597
[TBL] [Abstract][Full Text] [Related]
9. Anti-neurofascin autoantibody and demyelination.
Kira JI; Yamasaki R; Ogata H
Neurochem Int; 2019 Nov; 130():104360. PubMed ID: 30582947
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier.
Devaux JJ
Am J Pathol; 2012 Oct; 181(4):1402-13. PubMed ID: 22885108
[TBL] [Abstract][Full Text] [Related]
11. Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism.
Kira JI
Front Neurol; 2021; 12():665136. PubMed ID: 34177770
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype.
Cortese A; Lombardi R; Briani C; Callegari I; Benedetti L; Manganelli F; Luigetti M; Ferrari S; Clerici AM; Marfia GA; Rigamonti A; Carpo M; Fazio R; Corbo M; Mazzeo A; Giannini F; Cosentino G; Zardini E; Currò R; Gastaldi M; Vegezzi E; Alfonsi E; Berardinelli A; Kouton L; Manso C; Giannotta C; Doneddu P; Dacci P; Piccolo L; Ruiz M; Salvalaggio A; De Michelis C; Spina E; Topa A; Bisogni G; Romano A; Mariotto S; Mataluni G; Cerri F; Stancanelli C; Sabatelli M; Schenone A; Marchioni E; Lauria G; Nobile-Orazio E; Devaux J; Franciotta D
Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(1):. PubMed ID: 31753915
[TBL] [Abstract][Full Text] [Related]
13. Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies.
Vallat JM; Yuki N; Sekiguchi K; Kokubun N; Oka N; Mathis S; Magy L; Sherman DL; Brophy PJ; Devaux JJ
Neuromuscul Disord; 2017 Mar; 27(3):290-293. PubMed ID: 27986399
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
[TBL] [Abstract][Full Text] [Related]
15. Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features.
Tang L; Huang Q; Qin Z; Tang X
J Neurol; 2021 Aug; 268(8):2757-2768. PubMed ID: 32266541
[TBL] [Abstract][Full Text] [Related]
16. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.
Doppler K; Appeltshauser L; Wilhelmi K; Villmann C; Dib-Hajj SD; Waxman SG; Mäurer M; Weishaupt A; Sommer C
J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):720-8. PubMed ID: 25694474
[TBL] [Abstract][Full Text] [Related]
17. [Modern Perspectives on Peripheral Neuropathology].
Koike H
Brain Nerve; 2024 Apr; 76(4):361-374. PubMed ID: 38589281
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of Chronic Inflammatory Demyelinating Polyneuropathy: Insights into Classification and Therapeutic Strategy.
Koike H; Katsuno M
Neurol Ther; 2020 Dec; 9(2):213-227. PubMed ID: 32410146
[TBL] [Abstract][Full Text] [Related]
19. Behind the pathology of macrophage-associated demyelination in inflammatory neuropathies: demyelinating Schwann cells.
Park HT; Kim YH; Lee KE; Kim JK
Cell Mol Life Sci; 2020 Jul; 77(13):2497-2506. PubMed ID: 31884566
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies in chronic inflammatory demyelinating polyradiculoneuropathy.
Pascual-Goñi E; Martín-Aguilar L; Querol L
Curr Opin Neurol; 2019 Oct; 32(5):651-657. PubMed ID: 31306213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
